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1. Introduction 
 
 Iron is an essential element for virtually all living organisms. It is 
required as a cofactor for a multitude of proteins of diverse biological 
function. Iron plays a central role in oxygen transport by hemoglobin, in 
oxidation-reduction reactions, in cellular proliferation, and in many other 
biochemical pathways and physiological processes.  
 The dark side of the metal is, that in excess, it can be toxic. This is 
due to the deleterious effects of reactive oxygen species (ROS), such as the 
hydroxyl radical (OH•), which is produced via the Fenton reaction. The 
highly reactive hydroxyl radical is able to cause oxidative damage to DNA, 
proteins and biological membranes. These oxidative reactions can result in 
impairment of cellular functions, cellular damage and apoptosis. Because of 
this dual nature of iron, the concentration of the metal in mammalian body 
must be kept within defined limits and there are precise mechanisms 
governing the regulation of iron homeostasis. In humans there is no active 
mechanism for the excretion of iron, so the amount of iron in the body is 
determined by the regulation of iron absorption in the proximal small 
intestine. Consequently, iron levels are tightly regulated by specialized 
proteins, that transport and store iron in a soluble and non-toxic form. 
 Disruption of iron metabolism can lead to iron deficiency or iron 
overload. Iron overload is involved in the pathogenesis of many human 
diseases. Among all iron loading disorders, hereditary hemochromatosis and 
transfusion-dependent iron overload, are of utmost concern, considering 
their epidemiological impact, extent of iron burden, and risk for iron-related 
morbidity and mortality. Surplus iron in mammalian body accumulates in 
parenchymal organs, namely, in the liver, untreated iron overload leads to 
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liver fibrosis, cirrhosis, and cancer  (Pietrangelo, 2004). 
 Hereditary hemochromatosis (HH) type I is a genetic iron overload 
disease, associated with mutations in the HFE gene, with clinical 
consequences that can result in liver fibrosis, cirrhosis, diabetes, heart 
failure, arthritis or liver cancer (Feder et al., 1996). The protein encoded by 
HFE gene is similar to MHC class I-type proteins and associates with β2-
microglobulin (β2M). The majority of HH patients carry a mutation that 
prevents formation of a disulfide bond, impairing the physiological 
association of HFE with β2M. Lack of the association dramatically reduces 
cell surface expression of HFE (Pietrangelo, 2004). Molecular mechanism 
of hereditary hemochromatosis type I is unknown, despite the knowledge of 
underlying mutation in HFE protein. 
 
Our knowledge of pathophysiological processes connected with or 
triggered by iron deposition in liver is very limited. To get a deeper insight 
into the molecular pathology of iron overload, we studied the effect of iron 
overload in liver cells with the use of proteomic techniques. In the studies 
presented here, influence of acute and chronic iron overload on liver cells 
and liver was investigated in two different models: human hepatoma HepG2 
cells and C57BL/6J mice. Molecular mechanisms of genetic iron overload 
was studied in mouse model of hereditary hemochromatosis  (HFE-/- mice).   
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2.  Aims 
 
We focused our studies of molecular pathophysiology of liver iron overload 
on the three central questions: 
 
1. What changes in protein expression induces acute iron-
overload in liver cells? 
 
2. What changes in protein expression triggers chronic 
iron overload in liver?  
3. Are there any liver protein expression changes specific 
for hereditary hemochromatosis that are not caused by 
iron overload? 
 
 
 
We attempted to answer these questions with the help of proteomic methods 
described in the next paragraphs. 
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3. Methodical approach 
3.1. Proteomics 
 
The complete set of proteins present in a cell or a tissue in a given moment, 
including all protein modifications, interactions, localization and metabolic 
turnover, is called proteome. Any disturbance of protein expression, 
structure or localization may lead to disturbance of physiological processes 
and that may ultimately result in a disease. Proteomics, a relatively new set 
of modern techniques and approaches aims to quantitatively and 
qualitatively characterize all proteins present in a given moment in a given 
organism, tissue or cell. Expression proteomics aims to compare proteomes 
under various conditions.  
The starting material of a proteomic analysis is usually a mixture 
of hundreds or rather thousands of various proteins originating from cell 
cultures, tissues, body fluid or other sources. The principle of most 
proteomic experiments is to separate these mixtures (usually by 
electrophoresis or chromatography) and then to identify and quantify the 
individual proteins by mass spectrometry. In proteomics, the most often 
used tool of the protein separation is two-dimensional gel electrophoresis 
(2-DE), which we also used in our studies. 
The principle of 2-DE is two-dimensional electrophoretic 
separation of proteins based on two different physico-chemical properties of 
proteins. At first on the basis of their charge (isoelectric point) and then 
orthogonally on the by their molecular weight. Separated proteins are 
detected in 2-DE gels by staining. Routinely, up to 1500 individual protein 
spots can be detected in a single gel.  The resulting electrophoretogram 
represents a specific profile of protein expression in the given tissue. The 
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stained gels are scanned and subjected to a quantitative image analysis. The 
changes in intensity/size of spots, i.e. protein expression, are accurately 
quantified and the protein spots with signifaicantly changed intensities are 
cut out from the gel, digested with trypsin, and identified by mass 
spectrometry. 
 In our project, we used the classical method of expression 
proteomics - combination of 2-DE with mass spectrometry. We concentrated 
on: 
1) revealing the changes in protein expression elicited by: iron overload in 
cellular and animal model  
2) the protein expression changes characteristic for the mouse model of 
hereditary hemochromatosis. 
 Common methodical features of all three studies included in the presented 
thesis are summarized in the following workflow scheme: 
Manipulation of the model (changes of iron levels) → 
homogenisation of the sample (liver cell or liver tissue) → protein sample 
separation by 2-DE → staining, analysis of electrophoretograms and 
selection of differentially expressed protein spots → digestion by trypsin → 
extraction of peptides and identification by MS → verification of the results 
by an independent method (mRNA, Western blot). 
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4. Summary of results and discussion 
To get a deeper insight into the molecular pathophysiology of iron overload, 
we studied the effect of iron overload in liver and liver cells with the use of 
proteomic techniques. We focused our studies on answering the three 
central questions that defined our specific aims (see chapter 2). 
 
4.1. Aim One:   
 
What changes in protein expression induces acute iron-
overload in liver cells? 
   
In mammalian body, surplus iron is deposited in parenchymal 
organs, mainly in the liver. Therefore, we studied changes of protein 
expression in HepG2 cells induced by high levels of cellular iron. HepG2 
cells are derived form hepatocellular carcinoma and have most phenotypic 
characteristics of a standard hepatocyte, as for example: synthesis of alfa2-
macroglobulin, alfa1-antitrypsin, transferrin, alfa1-antichymotrypsin, 
haptoglobin, ceruloplasmin, and plasminogen (Knowles et Aden, 1983). 
After cultivation in a standard cell cultture media with addition of 1m M Fe 
(in the form of FeSO4) for 72 hours, these cells contained 13 times more 
internalized iron than control cells. Cell viability remained unafected. 
 With the help of 2-DE and mass spectrometry we discovered 
changes in expression of 21 protein spots (of 1060 protein spots) and 
identified 19 of them. Expression of 11 proteins was increased, 8 proteins 
were down-regulated as a result of acute iron overload. Some of the 
identified proteins have been associated with iron overload or oxidative 
stress previously, identification of others in the context of iron overload was 
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new. 
 
Iron overload, oxidative stress and PDI 
 As expected, expression of L-ferritin (iron storage protein) was 10 
times higher in FeSO4 treated HepG2 cells. However, even the massively 
increased ferritin expression did not prevent oxidative stress and lipid 
peroxidation in the iron-loaded HepG2 as was clearly demonstrated by 20-
fold increase in reactive lipid peroxides and aldehydes. 
Protein disulfide-isomerase (PDI), up-regulated in this experiment, 
is a multifunctional protein. PDI plays important role in corrective protein 
folding and also in collagen production, where it serves as beta subunit of 
prolyl 4-hydroxylase (P4H) (Wilkinson et Gilbert, 2004). We hypothesized 
that increased cellular iron induced not only PDI, but also the second 
subunit of the P4H complex. We tested the expression of the enzymatically 
active α1-subunit of prolyl 4-hydroxylase at the mRNA level in control and 
iron-overloaded HepG2 cells. We found out that α1-subunit mRNA was 
markedly decreased by iron overload. Therefore, we assume that the 
observed up-regulation of PDI reflects intrinsic functions of PDI, 
independent of P4H activity, namely, rearrangement of disulfide bridges. 
Therefore, we propose that increased PDI concentration compensates for 
higher need of corrective disulfide isomerization in iron-overloaded HepG2 
cells, where oxidative stress is significant.  
 
Laminin receptor, keratins  
 The laminin receptor, up-regulated in this experiment, is a protein 
with high-affinity to laminin. Laminins are a family of extracellular matrix 
proteins and represent the major noncollagenous glycoprotein found in the 
basement membrane. Laminins and the laminin receptor are involved in 
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many physiological processes, such as cell attachment, cell migration, 
growth, and differentiation. Laminin has been recently demonstrated to 
induce the expression of keratin 19 in hepatoma cells in culture. This 
process is thought to involve the laminin receptor (Su et al., 2003). We 
observed increased expression of the laminin receptor as well as of keratin 
19 and keratin 8 in response to iron overload. Therefore, we presume that 
there is a direct link of signal events connecting iron overload with 
increased expression of the laminin receptor and increased production of the 
cellular antistress protein keratin 19 in iron-loaded HepG2 cells. 
 
Enzymes and regulatory proteins 
 Among the proteins whose expression was down-regulated by iron 
overload was the transcriptional regulator KAP-1 (KRAB-associated 
protein). This protein is a universal corepressor for a large family of 
transcription factors, the KRAB domain-containing zinc finger proteins 
(Friedman et al., 1996). KAP-1 exerts its corepressive function in 
association with various proteins, for instance, with the chromatin 
remodeling protein HP-1 (Ryan et al., 1999), and histone deacetylase 
complexes (Underhill et al. 2000). Because KAP-1 is versatile molecule 
engaged in several regulatory processes, the significance of its down-
regulation in response to iron and oxidative stress may be very complex and 
remains to be elucidated. 
 A very surprising finding was the identification of a human 
homolog of anamorsin. Anamorsin is a cytokine-induced apoptosis inhibitor 
discovered in mice in 2004 (Shibayama et al., 2004). So far, nothing is 
known about the human anamorsin function and expression; we can only 
analogize based on the known mouse homolog. It has been demonstrated 
that mouse anamorsin is a critical antiapoptotic protein essential for 
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hematopoiesis. We presume that reduced expression of the human 
anamorsin homolog in response to iron and oxidative stress can signal an 
increased proapoptotic trend in oxidatively damaged cells. To our 
knowledge, our observation is the first piece of direct information provided 
on human anamorsin expression and its putative functions. 
Dihydrolipoamide dehydrogenase-binding protein (DDBP), down-
regulated by iron overload, is required for anchoring dihydrolipoamide 
dehydrogenase (E3) to the dihydrolipoamide transacetylase (E2) core of the 
pyruvate dehydrogenase complexes in mitochondria. We hypothesize that 
the observed decreased expression of protein DDBP in iron-overloaded 
HepG2 cells leads to a partial pyruvate decarboxylase deficiency and 
depletion of NADH with decrease of ATP production by mitochondria. This 
is in accordance with the disturbances of mitochondrial oxidative 
metabolism and decreased ATP production observed previously in cells 
exposed to excess iron (Bacon et al., 1993). 
 The expression changes of some other proteins (enolase 1 and 2, 
aldehyde dehydrogenase 2) are probably not related to iron metabolism, 
more likely these proteins respond to a general stress (Petrak et al., 2008). 
 In summary, by employing proteomic approaches, we identified 19 
proteins differentially expressed by iron overload and the consequent 
oxidative stress in human hepatoma cells. To our knowledge, this was the 
first attempt to use modern proteomic techniques to study iron overload in 
mammalian cells.  
 
 The results of our study were published in American Journal of 
Physiology in 2006: 
Petrak J, Myslivcova D, Man P, Cmejla R, Cmejlova J, Vyoral D. 
Proteomic analysis of iron overload in human hepatoma cells. Am J 
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Physiol Gastrointest Liver Physiol. 2006, 290(5): G1059-66. 
 
4.2. AimTwo:  
 
What changes in protein expression triggers chronic iron 
overload in liver?  
  
 For this set of experiments common inbred C57BL/6J mice were 
used as model organisms. Sixteen 3-months-old male mice were divided 
into two groups of eight animals and fed ad libitum with either defined 
standard rodent diet (C1000, Altromin, 180 ppm Fe) or the same diet 
supplemented with 2% carbonyl iron. 
 Iron overload induced by carbonyl iron-supplemented diet is 
known to result in a predominantly parenchymal iron deposition pattern 
similar to the iron deposition observed in hereditary hemochromatosis of 
type I. Liver iron concentration was increased ninefold in comparison with 
control animals fed standard diet. Animals in the overloaded group also 
displayed mild hepatomegaly. The iron-loaded liver showed signs of growth 
stimulation: anisokoria and increased number of hepatocytes with double 
nuclei and occasional mitoses. Also borderline microvesicular steatosis was 
observed. We have performed proteomic analysis of liver homogenates of 
control and iron loaded animals. We reproducibly detected 1020 (± 20) 
protein spots, out of which 32 displayed changed intensity.  We identified 30 
of the 32 protein spots by mass spectrometry.  
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Iron storage 
 As expected also in this experiment, we observed that the 
expression of the iron-storage protein ferritin was substantially increased in 
the iron-loaded livers (L-ferritin 6.7-fold, H-ferritin 3.7-fold). That provides 
further confirmation of effective liver iron overload in addition to direct 
liver iron measurement.  
 
Urea cycle 
 We observed increased levels of three enzymes of the urea cycle 
(carbamoyl-phosphate synthase, ornithine carbamoyltransferase, and 
arginase) in iron overload. Urea cycle is an essential five-enzyme system 
that converts toxic ammonia into urea. A connection of urea cycle with iron 
metabolism has not been previously established, and the role of urea cycle 
in iron overload remains to be elucidated. Interestingly, CAAT/enhancer-
binding protein (C/EBP alpha), a transcriptional regulator of the genes 
encoding these enzymes, has been previously shown to be increased by iron 
excess in mouse liver (Courselaud et al., 2002). C/EBP alpha also regulates 
expression of hepcidin, a key regulator of intestinal iron absorption, whose 
levels also increase in iron overload (Courselaud et al., 2002). It is 
noteworthy that the fifth enzyme of the urea cycle, arginase, competes with 
nitric oxide synthase for arginine, the sole substrate for nitric oxide 
production (Scaglia et al., 2004). Nitric oxide is known to play an important 
role in iron homeostasis by modulating the activity of iron regulatory 
proteins and non-transferrin iron transport (Hentze et Kuhn, 1996; 
Richardson et al., 1995). Nitric oxide also alters intracellular iron 
metabolism through iron release from ferritin (Reif et Simmons, 1990). 
Conversely, expression of inducible nitric oxide synthase is negatively 
regulated by iron (Weiss et al., 1994). Nitric oxide may therefore represent 
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the key link between the urea cycle and iron homeostasis in the liver.  
 
Peroxisomal fatty acid oxidation and sterol metabolism 
 We noted decreased levels of three enzymes of fatty acid oxidation 
pathway in iron-overload liver - peroxisomal 2-hydroxyphytanoyl-CoA 
lyase, peroxisomal enoyl CoA hydratase, and acetyl-CoA thioesterase 1. 
Decreased levels of these enzymes could indicate impaired fatty acid 
catabolism in the liver of iron-overloaded mice. Reduced fatty acid 
oxidation can contribute to the development of liver steatosis (Reddy, 
2001), often present in patients with hereditary hemochromatosis. 
Microvesicular steatosis, although very mild, was present in the liver of iron  
overloaded mice in our experiment.  
 
Methylation cycle and sarcosine dehydrogenase 
 Our study also revealed expression changes of two enzymes 
involved in methylation cycle and methionine metabolism (S-
adenosylhomocysteine hydrolase, glycine N’-methyltransferase). 
Adenosylmethonine (AdoMet)-dependent methylation has been shown to be 
central to many biological processes including gene regulation via DNA, 
protein methylation, and biosynthesis of phospholipids. S-
adenosylhomocysteine (AdoHcy), that is formed after donation of the 
activated methyl group of AdoMet to a methyl acceptor is a strong 
competitor of all AdoMet-dependent methyltransferases.  
 AdoHcy is removed by hydrolysis via S-adenosylhomocysteine 
hydrolase (which was decreased in iron overload). Glycine N’-
methyltransferase (increased in iron overload) catalyzes the methylation of 
glycine by using S-adenosylmethionine (AdoMet) to form AdoHcy and 
sarcosine, a molecule that has no known physiological role in mammals. 
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Glycine N’-methyltransferase functions to optimize the AdoMet-to- 
AdoHcy ratio, and consequently the cellular transmethylation potential 
(Kerr, 1972). Interestingly, sarcosine dehydrogenase, the enzyme that 
recycles sarcosine back to glycine, was also decreased in iron overload in 
our study.  
 We hypothesize that the observed decrease of S-
adenosylhomocysteine hydrolase combined with increased level of glycine 
N’-methyltransferase in iron overload could lead to accumulation of 
AdoHcy, and consequently to the inhibition of numerous AdoMet-
dependent methyltransferases. Decreased activity of these proteins can 
negatively affect phospholipids synthesis and methylation of proteins, small 
molecules, DNA, and RNA (Chiang et al., 1996). That could result in a  
multitude of negative biological effects. Iron-induced alterations of 
methylation pathway could potentially contribute to the liver damage 
observed in patients with iron overload diseases.  
 
The expression changes of some other proteins identified in our 
study (glutathione S-transferase Mu 6, glucose-regulated protein 78/luminal 
binding protein - GRP78/Bip) reflect more likely a general response of the 
cells to stress conditions than a specific response to high iron levels (Petrak 
et al., 2008). 
 In summary, we identified 30 proteins with altered levels in the 
liver of mice with nutritional iron overload. The proteins affected give us 
important clues into the significant metabolic changes in the iron-loaded 
liver. However, confirmation of the effects and the role of the particular 
metabolic pathways in molecular pathogenesis of iron overload remains to 
be determined in future studies.  
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Results of our study were published in American Journal of Physiology in 
2007: 
Petrak J, Myslivcova D, Man P, Cmejla R, Cmejlova J, Vyoral D, 
Elleder M, Vulpe CD. Proteomic analysis of hepatic iron overload in 
mice suggest dysregulation of urea cycle, impairment of fatty acid 
oxidation, and changes in the methylation cycle. Am J Physiol 
Gastrointest Liver Physiol. 2007, 292(6):G1490-8.  
 
4.3. Aim Three:  
 
Are there any liver protein expression changes specific for 
hereditary hemochromatosis that are not caused by iron 
overload? 
 
Molecular mechanism of hereditary hemochromatosis type I is 
unknown, despite the knowledge of underlying mutation in HFE protein. 
We intended to provide at least partial insight by identification of candidate 
proteins involved. 
 This set of experiments was designed to answer the critical question: 
What changes in protein expression are induced solely by the inactivation of 
HFE gene and not as a result of increased iron levels. We used a mouse 
model of hereditary hemochromatosis - mice with defective HFE protein 
expression (HFE-KO) (Zhou et al., 1998), showing gradual iron overload. 
To identify the specific changes induced by HFE protein defficiency, we 
compared HFE-KO mice with a control group of mice without the genetic 
defect (WT – wild type), both on the same genetic background C57B16/J.  
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A group of 4-weeks-old male WT mice were fed the standard rodent 
diet supplemented with 2% carbonyl iron for 8 days to reach hepatic iron 
concentration comparable with that observed in HFE-KO mice of the same 
age on a standard diet. The WT mice developed mild nutritional overload 
and HFE-KO mice were overloaded as a result of HFE deficiency. All 
changes in protein expression between the groups should therefore be 
caused by HFE deficiency, and be independent of iron loading. 
 We analysed liver homogenates of HFE-KO and WT mice by 2-
DE. We reproducibly detected 1150 ± 30 spots, out of which 20 showed 
changed expression. We identified 19 differentially expressed proteins by 
mass spectrometry. Next we will discuss the proteins with significantly 
altered expression. 
 
MUPs  
 Major urinary proteins 1, 2 and 6 (MUPs, up-regulated in HFE-
KO) belong to a family of small secreted proteins, lipocalins. Rodent major 
urinary proteins are synthesized predominantly in liver, released into serum, 
before being rapidly filtered by the kidney and excreted at very high 
concentrations in urine. Lipocalins play various roles are known to bind 
diverse low molecular weight ligands and to perform variety of functions. 
Interestingly, a member of the family, lipocalin 24p3 (human NGAL-
neutrophil gelatinase-associated lipocalin, lipocalin 2) can donate iron to 
various cells (Yang et al., 2002) via endocytic pathway. More interestingly, 
24p3 seems to be also capable of intracellular iron chelation and iron 
excretion (Ziegler et al., 2007).  
 We hypothesize, that MUP proteins can take part in iron transport 
or disposal of oxidatively damaged molecules. Our theory is supported by 
increased expression of MUPs in studies addressing liver protein expression 
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elicited by hepatotoxic drugs (Zgoda et al., 2006). However, the actual role 
of MUPs and other lipocalins in iron metabolism and hemochromatosis 
remains obscure. 
 
Glutathione-S-transferase P1  
 Glutathione-S-transferase P1 (up-regulated in HFE-KO) belongs to 
the GSTs superfamily of enzymes involved in cellular detoxication of toxic 
and carcinogenic compounds. In addition to its canonic function, 
glutathione-S-transferase P1 interferes with TNF-alpha signalling by 
association with TRAF2 (tumor necrosis receptor-associated factor 2) (Wu 
et al., 2006). Tumor necrosis factor α (TNF-α) is a cytokine with diverse 
functions which contributes to the regulation of iron metabolism by 
inhibiting intestinal iron absorption and iron release from peritoneal 
macrophages (Laftah et al., 2006) while also stimulating synthesis of ferritin 
and transferrin receptor (Alvarez et al., 1989). Based on the involvement of 
GST-P1 in the TNF-alpha signalling, it could be hypothesized, that GST-P1 
(induced by HFE disruption) in the HFE-KO mice can influence iron 
metabolism by abrogating TNF-alpha signalling.  
 
Selenium binding protein 2  
 The biological function of selenium binding protein 2 (SBP2) is 
not known. It is expressed predominantly in liver and represents a major 
target for acetaminophen toxicity (Pumford, et al., 1992). However, recently 
it was suggested that SBP2 is implicated in liver fibrosis (Henkel et al., 
2005).  
It is of interest, that expression of SBP2 in liver is reduced under 
peroxisome proliferator-activated receptor alpha (PPAR alpha) activation 
(Chu et al., 2004) and this PPAR alpha-related down-regulation is 
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accompanied by decreased expression of glutathione-S-transferase P1 and 
major urinary protein 2 (Chu et al., 2004).  
In our current study we observed an opposite regulation pattern – 
up-regulation – of these three proteins in the HFE-KO. This suggests that in 
HFE-KO mice we are witnessing a process adverse to the PPAR alpha 
activation. 
 
 
Carboxylesterase 1  
 Liver carboxylesterase 1 (CE1) is a broad spectrum serine esterase 
(Redinbo et al., 2003). The normal physiologic roles of the human ortholog 
hCE1 are in cholesterol and fatty acid metabolism. The human CE1 plays 
also an important role in xenobiotic metabolism and certain pro-drugs (for 
instance lovastatin - cholesterol lowering compound) are processed to their 
active forms by this enzyme. The down-regulation of liver carboxylase 1 (if 
confirmed in patients with herediatry hemochromatosis type I) would be of 
utmost clinical significance given the role of hCE1 in drug metabolism. 
 
 We identified a HFE hemochromatosis-specific protein expression 
pattern in the liver of HFE-KO mice. The pattern is not secondary to 
increased hepatic iron, but result directly from the HFE inactivation. 
Therefore, we hypothesize that the proteins differentially expressed in HFE-
KO animals are directly or indirectly involved in the molecular pathology of 
hereditary hemochromatosis type I. The particular roles of the differentially 
expressed proteins in hemochromatosis are yet to be elucidated. However, 
our data allows us to propose an involvement of lipocalins, and PPAR alpha 
regulatory pathway in the pathogenesis of hereditary hemochromatosis.  
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The results of our study were published in The International Journal of 
Biochemistry & Cell Biology in 2007: 
Petrak J, Myslivcova D, Halada P, Cmejla R, Cmejlova J, Vyoral D, 
Vulpe CD. Iron-independent specific protein expression pattern in the 
liver of HFE-deficient mice. Int J Biochem Cell Biol. 2007;39(5):1006-
15. 
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5. Conclusions 
 
 In our three presented analyses we identified three distinct sets of 
proteins involved in 1) response of liver (hepatoma) cells to acute iron 
toxicity, 2) response of liver to chronic nutritional iron overload and 3) 
pathophysiological mechanisms of hereditary hemochromatosis type I.    
 The results of our study have provided us with new information 
that will serve as a basis for future detailed studies addressing particular 
roles of individual candidate proteins or pathways in the context of iron 
metabolism.  Such studies are prerequisite for detailed understanding of 
molecular mechanisms involved in iron metabolism. Without the 
understanding of molecular pathophysiology it is impossible to imagine any 
progress in the development of new methods in prevention and therapy of 
diseases connected with iron metabolism, namely hemochromatosis and  
anemia  from chronic diseases. 
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